栄養補助食品添加剤市場規模、シェア、動向、2030年までの世界予測

栄養補助食品添加物市場は、2025年に49億8,000万米ドルに達すると推定され、予測期間中に7.4%のCAGRで成長し、2030年までに71億2,000万米ドルに達すると予測されています。

栄養補助食品添加剤市場は、世界中の消費者層における高品質、クリーンラベル、科学的根拠に基づいた栄養補助食品への需要の高まりを背景に、2030年まで着実な拡大が見込まれています。グミ、ソフトジェル、徐放錠、機能性飲料など、ブランド各社が先進的な剤形を次々と開発する中で、安定性、バイオアベイラビリティ、風味、そして製品全体の性能を向上させる添加剤の需要が高まっています。健康意識の高まりと、植物由来、天然、アレルゲンフリーの原料への移行が相まって、植物由来で持続可能な素材を原料とする新たな添加剤の採用が加速しています。植物由来カプセルシステム、多機能添加剤ブレンド、改良型溶解促進剤といった技術革新は、欧州や北米などの地域における強力な規制枠組みに支えられ、市場の成長をさらに促進しています。研究開発、処方の革新、製造の近代化への投資の増加に伴い、栄養補助食品添加物業界は、健康と栄養の幅広い分野における高性能で消費者中心のサプリメント開発の重要な推進役として浮上しています。

調査範囲

本調査レポートは、栄養補助食品添加剤市場を、原料（有機化学物質、無機化学物質、その他）、機能性（崩壊剤、着色料、潤滑剤・流動促進剤、保存料、乳化剤、その他の機能性）、最終製品（タンパク質・アミノ酸、オメガ3脂肪酸、ビタミン、ミネラル、プレバイオティクス、プロバイオティクス、その他の最終製品）、形状（乾燥、液体）、機能性用途（味覚マスキング剤、安定剤、放出制御剤、溶解性・生物学的利用能向上剤、その他の機能性用途）、および地域別に分類しています。本レポートは、栄養補助食品添加剤市場の成長に影響を与える主要な要因（促進要因、抑制要因、課題、機会など）に関する詳細な情報を網羅しています。主要業界プレーヤーの詳細な分析により、事業概要、ソリューション、サービス、主要戦略、契約、パートナーシップ、合意に関する洞察を提供しています。本調査には、栄養補助食品添加剤市場に関連する新製品・サービスの発売、合併・買収、最近の動向が含まれています。また、栄養補助食品添加剤市場エコシステムにおける新興スタートアップ企業の競合分析も含まれています。

このレポートを購入する理由

本レポートは、市場リーダー企業や新規参入企業にとって、栄養補助食品添加剤全体および各サブセグメントの収益数値の近似値に関する情報を提供するのに役立ちます。また、ステークホルダーが競争環境を理解し、事業のポジショニングを改善し、適切な市場開拓戦略を策定するための洞察を深めるのに役立ちます。さらに、本レポートは、ステークホルダーが市場の動向を把握し、主要な市場牽引要因、制約要因、課題、そして機会に関する情報を提供するのにも役立ちます。

本レポートは、以下の点について洞察を提供します。

• 種類、供給源、用途を網羅した詳細なセグメンテーション：本調査では、栄養補助食品添加剤市場を、供給源（有機化学物質、無機化学物質、その他）、機能性（崩壊剤、着色料、潤滑剤・流動化剤、保存料、乳化剤、その他の機能性）、最終製品（タンパク質・アミノ酸、オメガ3脂肪酸、ビタミン、ミネラル、プレバイオティクス、プロバイオティクス、その他の最終製品）に分類し、詳細な内訳を提示しています。また、味覚マスキング剤、安定剤、可溶化剤、放出制御添加剤などの主要な機能的役割についても分析しています。この包括的なセグメンテーションにより、関係者は成長著しい製剤分野を特定し、製品開発戦略を強化し、進化する栄養補助食品製造ニーズに合わせた製品・サービスの提供が可能になります。
• 新興市場に焦点を当てた地域固有の洞察：本レポートは、地域レベルおよび国レベルの詳細な評価を提供し、アジア太平洋、南米、中東といった高成長地域における拡大するビジネスチャンスに焦点を当てています。規制枠組み、クリーンラベル基準、そして植物由来、ヴィーガン、天然由来サプリメントへの消費者のシフトが、添加剤の採用を促進している状況を検証しています。さらに、栄養補助食品製造に対する政府の支援、高度な加工技術への投資、そして地域生産能力の向上についても概説しており、事業拡大、現地での提携、あるいは地域プレゼンスの強化を目指す企業にとって貴重な指針となります。
• 競合情報とイノベーション展望：ロケット、ケリーグループ、BASF、イングレディオン、DSMといった主要企業の詳細な競合プロファイルを提供し、戦略的取り組み、技術革新、事業拡大計画を網羅しています。本レポートでは、製品の発売、施設の拡張、合併・買収、研究開発活動といった主要な市場動向を追跡しています。これらの知見は、ステークホルダーが競合をベンチマークし、イノベーションの軌跡を理解し、栄養補助食品添加剤市場を形成する新たな製剤技術を活用するための支援となります。
• データに基づく手法に基づく需要予測：2030年までの市場規模予測と成長予測は、検証済みのトップダウンおよびボトムアップ分析アプローチに基づき、業界専門家の意見と検証済みの貿易データによって補完されています。これらの予測は、需要パターン、剤形ごとの添加剤消費動向、そして長期的な市場機会に関する信頼性の高い洞察を提供し、ステークホルダーの投資戦略策定と将来を見据えたポートフォリオの強化を支援します。

Report Description

The nutraceutical excipients market is estimated to be valued at USD 4.98 billion in 2025 and is projected to reach USD 7.12 billion by 2030, growing at a CAGR of 7.4% during the forecast period. The nutraceutical excipients market is projected to witness steady expansion through 2030, driven by the surging demand for high-quality, clean-label, and science-backed dietary supplements across global consumer groups. As brands innovate with advanced dosage forms—including gummies, softgels, controlled-release tablets, and functional beverages—there is a growing need for excipients that enhance stability, bioavailability, taste, and overall product performance. Rising health consciousness, coupled with the shift toward plant-based, natural, and allergen-free ingredients, is accelerating the adoption of novel excipients sourced from botanical and sustainable materials. Technological advancements such as plant-based capsule systems, multifunctional excipient blends, and improved solubility enhancers, supported by strong regulatory frameworks in regions like Europe and North America, are further propelling market growth. With increasing investments in R&D, formulation innovation, and manufacturing modernization, the nutraceutical excipients industry is emerging as a key enabler of high-performance and consumer-centric supplement development within the broader health and nutrition landscape.

“The dry formulation segment is estimated to witness a significant share during the forecast period.”

The dry nutraceutical excipients segment continues to dominate the market as manufacturers increasingly adopt powder-based ingredients for enhanced stability, extended shelf life, and ease of processing in tablets, capsules, and sachets. Dry excipients such as microcrystalline cellulose (MCC), lactose monohydrate, maltodextrin, prebiotic fibers, and silicon dioxide remain widely used for their superior flowability, compressibility, and bulking properties. Growing demand for clean-label and plant-derived nutraceuticals has also accelerated the use of bio-based dry excipients, including organic rice flour, acacia gum, and natural starch derivatives. Recent industry examples include Roquette’s launch of LYCOAT NG starch excipient for nutraceutical films in 2024, DFE Pharma’s expansion of its dry powder excipients portfolio for dietary supplements, and BASF’s introduction of dry-coated solutions to improve tablet performance. These innovations are strengthening the role of dry excipients as essential functional ingredients supporting formulation efficiency and high-quality nutraceutical product development.

“The taste masking functionality segment is the fastest to maintain robust growth.”

Taste masking has become the fastest-growing functionality in the nutraceutical excipients market as brands increasingly incorporate bitter plant extracts, minerals, amino acids, and next-generation bioactives into consumer-friendly formats. With rising demand for gummies, chewables, effervescent, and orally disintegrating powders, manufacturers now rely on excipients that can effectively reduce bitterness, metallic notes, and strong herbal flavors. This shift has accelerated the use of cyclodextrins for inclusion complexation, lipid-based carriers to block taste receptor interaction, and modified starches for microencapsulation. New developments are reinforcing this momentum, such as Ingredion’s 2024 clean-label encapsulation starches for flavor modulation, Ashland’s recent Klucel HPC grades optimized for taste-masked chewables, and Kerry’s release of Enmask™ natural flavor-modulating systems for active-rich supplements. As consumer expectations for pleasant-tasting nutraceuticals rise—especially in pediatric, sports nutrition, and women’s health products—taste masking is rapidly becoming a critical performance driver, solidifying its position as the fastest-expanding application area in nutraceutical excipients.

“Europe is estimated to account for a significant share of the nutraceutical excipients market.”

Europe holds a significant share in the nutraceutical excipients market, driven by the strong presence of leading global players and a steady rise in innovative product launches across the region. Countries such as Germany, France, the UK, and Switzerland serve as key hubs for pharmaceutical and nutraceutical manufacturing, supported by advanced R&D capabilities and strict quality standards that encourage the development of next-generation excipients. Major companies like Roquette, BASF, Kerry, and IMCD continue to expand their portfolios, with recent launches such as Roquette’s LYCAGEL® Flex softgel capsule shell system introduced at Vitafoods Europe 2024, reinforcing the region’s leadership in plant-based and functional excipient solutions. These innovations cater to Europe’s rapidly growing demand for vegan, clean-label, and high-performance nutraceutical formulations. The combination of well-established excipient manufacturers, continuous technological advancements, and a strong regulatory framework firmly positions Europe as a dominant and fast-evolving market for nutraceutical excipients.

In-depth interviews were conducted with chief executive officers (CEOs), directors, and other executives from various key organizations operating in the nutraceutical excipients market:

• By Company Type: Tier 1 – 25%, Tier 2 – 45%, and Tier 3 – 30%
• By Designation: Directors – 20%, Managers – 50%, Executives – 30%
• By Region: North America – 25%, Europe – 30%, Asia Pacific – 20%, South America – 15%, and Rest of the World (Middle East and Africa) – 10%

Prominent companies in the market include International Flavors & Fragrances Inc. (US), Kerry Group plc (Ireland), Ingredion (US), Sensient Technologies Corporation (US), Associated British Foods plc (UK), BASF SE (Germany), Roquette Frères (France), MEGGLE GmbH & Co. KG (Germany), Cargill, Incorporated (US), Ashland (US), IMCD (Netherlands), Hilmar Cheese Company, Inc. (US), SEPPIC (US), and Azelis Group (Luxembourg).

Research Coverage

This research report categorizes the nutraceutical excipients market by source (organic chemicals, inorganic chemicals, others), functionality (disintegrants,  colorants, lubricants & glidants, preservatives, emulsifying agents, other functionalities), end product (proteins & amino acids, omega-3 fatty acids, vitamins, minerals, prebiotics, probiotics, other end products), form (dry, liquid), functionality application (taste masking, stabilizers, modified release, solubility & bioavailability enhancers, other functionality applications), and region. The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the nutraceutical excipients market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, and services; key strategies; Contracts, partnerships, and agreements. The study includes new product & service launches, mergers & acquisitions, and recent developments associated with the nutraceutical excipients market. This report also includes a competitive analysis of emerging startups in the nutraceutical excipients market ecosystem.

Reasons to Buy this Report

The report will help market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall nutraceutical excipients and the subsegments. It will also help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights into the following points:

• In-depth Segmentation across Type, Source, and Application: This study presents a detailed breakdown of the nutraceutical excipients market, categorizing it source (organic chemicals, inorganic chemicals, others), functionality (Disintegrants, Colorants, Lubricants & Glidants, Preservatives, Emulsifying Agents, Other Functionalities), end product (Proteins & Amino Acids, Omega-3 Fatty Acids, Vitamins, Minerals, Prebiotics, Probiotics, Other End Products). The analysis also covers key functional roles such as taste masking agents, stabilizers, solubilizers, and release-modifying excipients. This holistic segmentation enables stakeholders to identify high-growth formulation areas, enhance product development strategies, and align offerings with evolving nutraceutical manufacturing needs.
• Region-specific Insights with Focus on Emerging Markets: The report offers an in-depth regional and country-level assessment, highlighting expanding opportunities across high-growth regions such as the Asia Pacific, South America, and the Middle East. It examines regulatory frameworks, clean-label norms, and consumer shifts toward plant-based, vegan, and natural supplements, driving excipient adoption. Additionally, it outlines government support for nutraceutical manufacturing, investments in advanced processing technologies, and rising local production capabilities—providing valuable guidance for companies seeking to scale, partner locally, or strengthen regional presence.
• Competitive Intelligence and Innovation Landscape: Detailed competitive profiles of leading players—including Roquette, Kerry Group, BASF, Ingredion, and DSM—are provided, covering their strategic initiatives, technological advancements, and expansion plans. The report tracks major market developments such as product launches, facility expansions, mergers and acquisitions, and R&D activities. These insights equip stakeholders to benchmark competition, understand innovation trajectories, and capitalize on emerging formulation technologies shaping the nutraceutical excipients market.
• Demand Forecasts Backed by Data-driven Methodologies: Market size projections and growth estimates through 2030 are based on validated top-down and bottom-up analytical approaches, supplemented by industry expert inputs and verified trade data. The forecasts deliver reliable insights into demand patterns, excipient consumption trends across dosage forms, and long-term market opportunities, helping stakeholders strategize investments and strengthen future-ready portfolios.

Table of Contents

1 INTRODUCTION 35
1.1 STUDY OBJECTIVES 35
1.2 MARKET DEFINITION 35
1.3 STUDY SCOPE 36
1.3.1 MARKET SEGMENTATION AND REGIONS COVERED 36
1.3.2 INCLUSIONS AND EXCLUSIONS 37
1.3.3 YEARS CONSIDERED 38
1.4 UNITS CONSIDERED 39
1.4.1 CURRENCY CONSIDERED 39
1.5 STAKEHOLDERS 39
1.6 SUMMARY OF CHANGES 40
2 EXECUTIVE SUMMARY 41
2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS 41
2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND STRATEGIC DEVELOPMENTS 43
2.3 DISRUPTIVE TRENDS SHAPING MARKET 44
2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS 45
2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST 46
3 PREMIUM INSIGHTS 48
3.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN NUTRACEUTICAL EXCIPIENTS MARKET 48
3.2 NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE AND REGION 49
3.3 NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION 50
3.4 NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION 50
3.5 NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE 51
3.6 NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION 51
3.7 NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT 52
3.8 NUTRACEUTICAL EXCIPIENTS MARKET, BY COUNTRY 52
4 MARKET OVERVIEW 53
4.1 INTRODUCTION 53
4.2 MARKET DYNAMICS 53
4.2.1 DRIVERS 54
4.2.1.1 Increased focus on preventive care to encourage investments in products/solutions 54
4.2.1.2 Advancements in nanotechnology equipped with new features relating to nutraceutical excipients 55
4.2.1.3 Rising investments in clean-label and natural excipients driven by regulatory pressure and shifting consumer health preferences 56
4.2.1.4 Mandates on food fortification by government organizations 57
4.2.2 RESTRAINTS 58
4.2.2.1 Decrease in returns on R&D investments and high costs of clinical trials and registration 58
4.2.2.2 Stringent regulatory expectations for excipient safety, purity, and compliance, adding complexity to product approvals 59
4.2.3 OPPORTUNITIES 59
4.2.3.1 Multi-functionalities of excipients aiding in saving costs and processing time 59
4.2.3.2 Rising awareness of micronutrient deficiencies 60
4.2.3.3 Growing popularity of gummy supplements 61
4.2.4 CHALLENGES 61
4.2.4.1 Consumer skepticism associated with nutraceutical products due to rural and semi-urban consumers’ perception of dietary supplements as pharmaceutical drugs 61
4.2.4.2 Ensuring compatibility with high-potency actives 62
4.3 UNMET NEEDS AND WHITE SPACES 63
4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 64
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 65
5 INDUSTRY TRENDS 67
5.1 INTRODUCTION 67
5.2 PORTER’S FIVE FORCES ANALYSIS 67
5.2.1 INTENSITY OF COMPETITIVE RIVALRY 68
5.2.2 BARGAINING POWER OF SUPPLIERS 69
5.2.3 BARGAINING POWER OF BUYERS 69
5.2.4 THREAT OF SUBSTITUTES 69
5.2.5 THREAT OF NEW ENTRANTS 70
5.3 MACROECONOMIC INDICATORS 70
5.3.1 GLOBAL POPULATION WITNESSING HIGH PREVALENCE OF OBESITY 70
5.3.2 AGING POPULATION BECOMING MORE AWARE OF BENEFITS OF NUTRACEUTICALS 71
5.4 SUPPLY CHAIN ANALYSIS 72
5.5 VALUE CHAIN ANALYSIS 73
5.5.1 SOURCING OF RAW MATERIALS 74
5.5.2 MANUFACTURING 74
5.5.3 DISTRIBUTION, MARKETING, AND SALES 74
5.6 ECOSYSTEM/MARKET MAP 74
5.6.1 UPSTREAM 74
5.6.1.1 Excipient manufacturers 74
5.6.1.2 Technology providers 74
5.6.2 DOWNSTREAM 75
5.6.2.1 Regulatory bodies 75
5.6.2.2 Nutraceutical manufacturers 75

5.7 PRICING ANALYSIS 77
5.7.1 INDICATIVE AVERAGE SELLING PRICE, BY SOURCE 77
5.7.2 AVERAGE SELLING PRICE TREND, BY REGION 78
5.8 TRADE ANALYSIS 79
5.8.1 TRADE ANALYSIS OF HS CODE 210690 79
5.8.1.1 Export trends of nutraceutical excipient under HS Code 210690 80
5.8.1.2 Import trends of nutraceutical excipients under HS Code 210690 80
5.8.2 TRADE ANALYSIS OF HS CODE 300490 81
5.8.2.1 Export trends of nutraceutical excipients under HS Code 300490 81
5.8.2.2 Import trends of nutraceutical excipients under HS Code 300490 82
5.8.3 TRADE ANALYSIS OF HS CODE 293090 83
5.8.3.1 Export trends of nutraceutical excipient under HS Code 293090 83
5.8.3.2 Import trends of nutraceutical excipients under HS Code 293090 84
5.8.4 TRADE ANALYSIS OF HS CODE 382200 84
5.8.4.1 Export trends of nutraceutical excipient under HS Code 382200 85
5.8.4.2 Import trends of nutraceutical excipient under HS Code 382200 85
5.9 KEY CONFERENCES & EVENTS 86
5.10 TRENDS IMPACTING CUSTOMERS’ BUSINESSES 87
5.11 INVESTMENT AND FUNDING SCENARIO 88
5.12 CASE STUDY ANALYSIS 88
5.12.1 BENEO’S GALENIQ® MULTIFUNCTIONAL FILLER-BINDER FOR CLEAN-LABEL TABLETS (CPHI 2025) 88
5.12.2 ROQUETTE READILYCOAT® LOW-TEMPERATURE COATING SYSTEM (2025) 88
5.12.3 EVONIK – LIPID-BASED CARRIER FOR OMEGA-3 CAPSULES (APRIL 2024) 89
5.13 IMPACT OF 2025 US TARIFF – NUTRACEUTICAL EXCIPIENTS MARKET 89
5.13.1 INTRODUCTION 89
5.13.2 KEY TARIFF RATES 90
5.13.3 PRICE IMPACT ANALYSIS 90
5.13.4 IMPACT ON COUNTRY/REGION 91
5.13.5 IMPACT ON END-USE INDUSTRY 92
6 STRATEGIC DISRUPTION THROUGH TECHNOLOGY, PATENTS, DIGITAL, AND AI ADOPTIONS 93
6.1 INTRODUCTION 93
6.2 KEY EMERGING TECHNOLOGIES 93
6.3 COMPLEMENTARY TECHNOLOGIES 94
6.4 TECHNOLOGY/PRODUCT ROADMAP 96
6.5 PATENT ANALYSIS 97
6.5.1 LIST OF MAJOR PATENTS 98
6.6 FUTURE APPLICATIONS 103
6.7 IMPACT OF AI/GEN AI ON NUTRACEUTICAL EXCIPIENTS MARKET 104
6.7.1 TOP USE CASES AND MARKET POTENTIAL 104
6.7.2 BEST PRACTICES IN NUTRACEUTICAL EXCIPIENT PROCESSING 105
6.7.3 CASE STUDIES OF AI IMPLEMENTATION IN NUTRACEUTICAL EXCIPIENTS MARKET 106
6.7.3.1 AI-driven Ingredient Discovery & Formulation Optimization 106
6.7.3.2 AI-Enabled Evidence Review and Product Rationalization (2025) 106
6.7.4 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS 107
6.7.5 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN NUTRACEUTICAL EXCIPIENTS MARKET 107
6.8 SUCCESS STORIES AND REAL-WORLD APPLICATIONS 108
7 SUSTAINABILITY AND REGULATORY LANDSCAPE 109
7.1 INTRODUCTION 109
7.2 REGIONAL REGULATIONS AND COMPLIANCE 109
7.2.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 110
7.2.2 INDUSTRY STANDARDS 113
7.2.2.1 Organizations/Regulations governing nutraceutical excipients market 113
7.2.2.2 North America 114
7.2.2.2.1 Canada 114
7.2.2.2.2 US 114
7.2.2.2.3 Mexico 115
7.2.2.3 European Union (EU) 115
7.2.2.4 Asia Pacific 115
7.2.2.4.1 Japan 115
7.2.2.4.2 China 115
7.2.2.4.3 India 116
7.2.2.4.4 Australia & New Zealand 116
7.2.2.5 Rest of the World (RoW) 116
7.2.2.5.1 Brazil 116
7.2.2.6 Probiotics 116
7.2.2.6.1 Introduction 116
7.2.2.6.2 National/International bodies for safety standards and regulations 117
7.2.2.6.3 Codex Alimentarius Commission (CAC) 117
7.2.2.6.4 North America: regulatory environment analysis 117
7.2.2.6.4.1 US 118
7.2.2.6.4.2 Canada 119
7.2.2.6.5 Asia Pacific: Regulatory environment analysis 119
7.2.2.6.5.1 Japan 120
7.2.2.6.5.2 India 120
7.2.2.6.6 South America: Regulatory Environment Analysis 121
7.2.2.6.6.1 Brazil 121
7.2.2.7 Prebiotics 121
7.2.2.7.1 Introduction 121
7.2.2.7.2 Asia Pacific 121
7.2.2.7.2.1 Japan 121
7.2.2.7.2.2 Australia & New Zealand 121
7.2.2.7.2.3 South Korea 122
7.2.2.7.2.4 India 122
7.2.2.7.3 North America 122
7.2.2.7.3.1 US 122
7.2.2.7.3.2 Canada 122
7.2.2.7.4 European Union 124
7.3 SUSTAINABILITY INITIATIVES 124
7.3.1 ADOPTION OF PLANT-BASED AND UPCYCLED RAW MATERIALS 124
7.3.2 IMPLEMENTATION OF ENERGY-EFFICIENT PROCESSING TECHNOLOGIES 126
7.4 SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES 127
7.5 CERTIFICATIONS, LABELING, ECO-STANDARDS 127
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 130
8.1 INTRODUCTION 130
8.2 DECISION-MAKING PROCESS 130
8.3 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA 131
8.3.1 KEY STAKEHOLDERS IN BUYING PROCESS 131
8.3.2 BUYING CRITERIA 132
8.4 ADOPTION BARRIERS & INTERNAL CHALLENGES 134
8.5 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 134
8.6 MARKET PROFITABILITY 135
9 NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT 136
9.1 INTRODUCTION 137
9.2 PROBIOTICS 138
9.2.1 GROWING STABILITY REQUIREMENTS OF PROBIOTIC INGREDIENTS TO DRIVE MARKET 138
9.3 PREBIOTICS 140
9.3.1 INCREASING FORMULATION NEEDS FOR STABLE PREBIOTIC INGREDIENTS TO DRIVE MARKET 140
9.4 PROTEINS & AMINO ACIDS 141
9.4.1 GROWING FORMULATION REQUIREMENTS FOR STABLE PROTEIN AND AMINO ACID INGREDIENTS TO DRIVE MARKET 141
9.5 VITAMINS 142
9.5.1 PREVALENCE OF VITAMIN DEFICIENCIES AMONG CONSUMERS TO DRIVE MARKET GROWTH FOR NUTRACEUTICAL EXCIPIENTS 142
9.6 MINERALS 144
9.6.1 BENEFITS OFFERED FOR OPTIMAL FUNCTIONING OF BRAIN AND HEART TO DRIVE GROWTH OF NUTRACEUTICAL EXCIPIENTS MARKET 144
9.7 OMEGA-3 FATTY ACIDS 145
9.7.1 INCREASE IN HEART DISEASES TO DRIVE DEMAND FOR OMEGA-3 FATTY ACID SUPPLEMENTS 145
9.8 OTHER END PRODUCTS 146
10 NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE 148
10.1 INTRODUCTION 149
10.2 ORGANIC CHEMICALS 150
10.2.1 OLEOCHEMICALS 151
10.2.1.1 Fatty alcohols 152
10.2.1.1.1 Need for enhancing texture and creaminess likely to propel demand 152
10.2.1.2 Mineral stearates 153
10.2.1.2.1 Mineral stearates to reduce friction and avoid equipment clogging during manufacturing of nutraceuticals 153
10.2.1.3 Glycerin 153
10.2.1.3.1 Glycerin to help improve smoothness and lubrication process 153
10.2.1.4 Other oleochemicals 153
10.2.2 CARBOHYDRATES 153
10.2.2.1 Sugars 154
10.2.2.1.1 Actual sugars 155
10.2.2.1.1.1 Rising diabetic population to fuel need for low-glycemic index alternatives like xylitol and isomaltulose 155
10.2.2.1.2 Sugar alcohols 156
10.2.2.1.2.1 Various advantageous and unique properties of sugar alcohols to make them an attractive option 156
10.2.2.1.3 Artificial sweeteners 156
10.2.2.1.3.1 Emerging trends in utilization of natural sweeteners in nutraceutical products to drive demand 156
10.2.2.2 Cellulose 157
10.2.2.2.1 Microcrystalline cellulose 158
10.2.2.2.1.1 Rising nutraceutical trend to bolster microcrystalline cellulose demand for superior tablet integrity 158
10.2.2.2.2 Cellulose ethers 158
10.2.2.2.2.1 Cellulose ethers help streamline nutraceutical rheology 158
10.2.2.2.3 CMC & croscarmellose sodium 159
10.2.2.2.3.1 Enhanced mouthfeel and fast-acting properties to help propel market growth 159
10.2.2.2.4 Cellulose esters 159
10.2.2.2.4.1 Rising demand for cellulose esters to provide a technical edge in nutraceuticals 159
10.2.2.3 Starch 159
10.2.2.3.1 Modified starch 160
10.2.2.3.1.1 Technical advancements to fuel modified starch demand in nutraceutical excipient industry 160
10.2.2.3.2 Dried starch 161
10.2.2.3.2.1 Capabilities such as disintegration enhancement and bulking effects to drive market 161
10.2.2.3.3 Converted starch 161
10.2.2.3.3.1 Properties such as increased solubility to boost nutrient absorption 161
10.2.3 PETROCHEMICALS 161
10.2.3.1 Glycols 162
10.2.3.1.1 Humectant & solvent properties to drive demand 162
10.2.3.2 Povidones 163
10.2.3.2.1 Film-forming function to provide controlled release of active ingredients 163
10.2.3.3 Mineral hydrocarbons 163
10.2.3.3.1 Properties such as antifoaming and lubrication to help in nutraceutical manufacturing 163
10.2.3.4 Acrylic polymers 163
10.2.3.4.1 Diverse functions of acrylic polymers in nutraceuticals to propel growth 163
10.2.3.5 Other petrochemical excipients 164
10.2.4 PROTEINS 164
10.2.4.1 Expanding utilization of proteins as carriers for microparticles and nanoparticles to propel market growth 164
10.2.5 OTHER ORGANIC CHEMICALS 164
10.3 INORGANIC CHEMICALS 165
10.3.1 CALCIUM PHOSPHATE 166
10.3.1.1 Nutraceutical production to be optimized by utilizing GMO-free calcium phosphates as GRAS excipients 166
10.3.2 METAL OXIDES 166
10.3.2.1 Metal oxides to help meet rising demand for iron-enriched nutraceuticals 166
10.3.3 HALITES 167
10.3.3.1 Halites to ensure taste improvement and salting-out techniques 167
10.3.4 CALCIUM CARBONATE 167
10.3.4.1 Focus on R&D of calcium carbonate to help launch new products 167
10.3.5 CALCIUM SULFATE 168
10.3.5.1 Improved flowability to drive demand for calcium sulfate 168
10.3.6 OTHER INORGANIC CHEMICALS 168
10.4 OTHER CHEMICALS 168
11 NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION 170
11.1 INTRODUCTION 171
11.2 TASTE MASKING 172
11.2.1 CREATING DIFFERENTIATION IS KEY IN THIS COMPETITIVE MARKET 172

11.3 STABILIZERS 173
11.3.1 MAINTAINING DESIRABLE PROPERTIES UNTIL CONSUMPTION TO DRIVE DEMAND FOR STABILIZERS 173
11.4 MODIFIED RELEASE 174
11.4.1 NEED FOR SLOWER AND STEADIER RELEASE OF COMPOUNDS TO PROPEL GROWTH OF MODIFIED-RELEASE APPLICATIONS IN NUTRACEUTICAL EXCIPIENTS MARKET 174
11.5 SOLUBILITY & BIOAVAILABILITY ENHANCEMENT 175
11.5.1 CHALLENGES RELATED TO POOR SOLUBILITY AND LIMITED ABSORPTION OF BIOACTIVE COMPOUNDS TO DRIVE DEMAND 175
11.6 OTHER FUNCTIONALITY APPLICATIONS 177
12 NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION 178
12.1 INTRODUCTION 179
12.2 DRY 180
12.2.1 TABLETS 182
12.2.1.1 Easy-to-carry and portable nature makes them attractive option 182
12.2.2 CAPSULES 182
12.2.2.1 Quick-dissolving capsule shells for targeted absorption are ideal for nutraceuticals designed to act in specific areas of digestive tract 182
12.3 LIQUID 183
12.3.1 POTENTIAL GROWTH OPPORTUNITIES FOR LIQUID NUTRACEUTICAL EXCIPIENTS DUE TO INNOVATIONS IN FORMULATIONS TO DRIVE GROWTH 183
12.4 OTHER FORMULATIONS 184
13 NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY 185
13.1 INTRODUCTION 186
13.2 BINDERS 188
13.2.1 INCREASED ACCEPTANCE AND USE OF BINDING AGENTS IN PRODUCTS TO DRIVE GROWTH OF NUTRACEUTICAL EXCIPIENTS MARKET 188
13.3 FILLERS & DILUENTS 189
13.3.1 USE OF ACTIVE INGREDIENTS IN NUTRACEUTICAL PRODUCTS TO ENCOURAGE USE OF FILLERS AND DILUENTS AS EXCIPIENTS 189
13.4 DISINTEGRANTS 190
13.4.1 HIGH CONSUMPTION OF DIETARY SUPPLEMENTS IN FORM OF ORAL DOSAGES OR TABLETS TO DRIVE GROWTH OF DISINTEGRANTS SEGMENT 190
13.5 COATING AGENTS 191
13.5.1 PROTECTION FROM MOISTURE AND BACTERIA TO DRIVE DEMAND 191
13.6 FLAVORING AGENTS & SWEETENERS 192
13.6.1 INCREASE IN NEED FOR MASKING STRONG AND UNAPPEALING FLAVORS TO DRIVE GROWTH OF SEGMENT 192
13.7 PRESERVATIVES 193
13.7.1 INHIBITION OF MICROBIAL GROWTH AND MAINTAINING PRODUCT QUALITY AND SAFETY TO DRIVE DEMAND FOR PRESERVATIVES 193

13.8 LUBRICANTS & GLIDANTS 194
13.8.1 INCREASE IN NEED FOR REDUCING FRICTION AND KEEPING FORMULATION INTACT DURING PRODUCTION PROCESS TO DRIVE GROWTH OF SEGMENT 194
13.9 SUSPENDING & VISCOSITY AGENTS 195
13.9.1 PREVENTING SETTLING TO HELP MAINTAIN HOMOGENEITY AND STABILITY OF PRODUCT 195
13.10 COLORANTS 196
13.10.1 NEED FOR VISUAL APPEAL AND PRODUCT DIFFERENTIATION TO FUEL DEMAND FOR COLORANTS 196
13.11 EMULSIFYING AGENTS 197
13.11.1 NEED FOR REDUCING SURFACE TENSION BETWEEN DIFFERENT COMPONENTS TO DRIVE DEMAND FOR EMULSIFYING AGENTS 197
13.12 OTHER FUNCTIONALITIES 198
14 NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION 200
14.1 INTRODUCTION 201
14.2 NORTH AMERICA 204
14.2.1 US 209
14.2.1.1 High concentration of key players, various nutrition awareness programs, and increase in preventive healthcare trends in US 209
14.2.2 CANADA 210
14.2.2.1 Demand for quality and cost-competition: Two key factors for manufacturers to consider in Canada 210
14.2.3 MEXICO 212
14.2.3.1 Increase in foreign direct investments and rise in awareness regarding healthier lifestyles associated with dietary supplements 212
14.3 EUROPE 213
14.3.1 GERMANY 218
14.3.1.1 Demand for nutraceutical excipients is likely to increase to serve health-conscious consumers 218
14.3.2 FRANCE 220
14.3.2.1 Innovations in product formulations to cater to increased consumer demands 220
14.3.3 UK 221
14.3.3.1 Growth of functional/fortified food & beverage industry in UK to drive demand for nutraceutical excipients 221
14.3.4 ITALY 223
14.3.4.1 Growing trend of online OTC and food supplement purchases in Italy 223
14.3.5 SPAIN 224
14.3.5.1 Excipient manufacturers expand Iberian operations to support tablets and capsules marketed across Spain 224
14.3.6 REST OF EUROPE 226
14.4 ASIA PACIFIC 227
14.4.1 CHINA 233
14.4.1.1 Rise in preference for nutraceutical products and innovations in dietary supplement formulations and fortified food products 233
14.4.2 JAPAN 235
14.4.2.1 Manufacturers should think beyond pills & innovation to tap this growing market in Japan 235
14.4.3 INDIA 236
14.4.3.1 Government policies and importance of nutraceuticals in daily life 236
14.4.4 SOUTH KOREA 238
14.4.4.1 Rapid growth of supplements industry in South Korea 238
14.4.5 REST OF ASIA PACIFIC 240
14.5 SOUTH AMERICA 241
14.5.1 BRAZIL 246
14.5.1.1 Growth in awareness regarding the benefits of functional foods and rise in aging population in Brazil 246
14.5.2 ARGENTINA 247
14.5.2.1 Country’s focus on prevention healthcare system to be positive sign for nutraceutical excipients market 247
14.5.3 REST OF SOUTH AMERICA 249
14.6 REST OF THE WORLD (ROW) 250
14.6.1 MIDDLE EAST 255
14.6.1.1 Rise in obesity and other health-related concerns in Middle East 255
14.6.2 AFRICA 256
14.6.2.1 Intra-African trade policies and investments by global nutraceutical players 256
15 COMPETITIVE LANDSCAPE 258
15.1 OVERVIEW 258
15.2 KEY PLAYER COMPETITIVE STRATEGIES/RIGHT TO WIN, 2020–2024 259
15.3 REVENUE ANALYSIS, 2022–2024 261
15.4 MARKET SHARE ANALYSIS, 2024 262
15.5 BRAND/PRODUCT COMPARISON 264
15.5.1 KERRY GROUP PLC (IRELAND) 264
15.5.2 INGREDION (US) 265
15.5.3 BASF (GERMANY) 265
15.5.4 ASSOCIATED BRITISH FOODS PLC (UK) 265
15.5.5 SENSIENT TECHNOLOGIES CORPORATION (US) 265
15.6 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 265
15.6.1 STARS 266
15.6.2 EMERGING LEADERS 266
15.6.3 PERVASIVE PLAYERS 266
15.6.4 PARTICIPANTS 266
15.6.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 268
15.6.5.1 Company footprint 268
15.6.5.2 Region footprint 269
15.6.5.3 Source footprint 270
15.6.5.4 Functionality footprint 271
15.6.5.5 Functionality application footprint 272
15.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 273
15.7.1 PROGRESSIVE COMPANIES 273
15.7.2 RESPONSIVE COMPANIES 273
15.7.3 DYNAMIC COMPANIES 273
15.7.4 STARTING BLOCKS 273
15.7.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 275
15.7.5.1 Detailed list of key startups/SMEs 275
15.7.5.2 Competitive benchmarking of key startups/SMEs 276
15.8 COMPANY VALUATION AND FINANCIAL METRICS 277
15.8.1 COMPANY VALUATION 277
15.8.2 EV/EBITDA 277
15.9 COMPETITIVE SCENARIO 278
15.9.1 PRODUCT LAUNCHES 278
15.9.2 DEALS 279
15.9.3 EXPANSIONS 282
15.9.4 OTHER DEVELOPMENTS 283
16 COMPANY PROFILES 284
16.1 KEY PLAYERS 284
16.1.1 KERRY GROUP PLC 284
16.1.1.1 Business overview 284
16.1.1.2 Product/Solutions/Services offered 285
16.1.1.3 Recent developments 287
16.1.1.4 MnM view 288
16.1.1.4.1 Right to win 288
16.1.1.4.2 Strategic choices 288
16.1.1.4.3 Weaknesses and competitive threats 288
16.1.2 INGREDION 289
16.1.2.1 Business overview 289
16.1.2.2 Product/Solutions/Services offered 290
16.1.2.3 Recent developments 291
16.1.2.3.1 Deals 291
16.1.2.4 MnM view 291
16.1.2.4.1 Right to win 291
16.1.2.4.2 Strategic choices 291
16.1.2.4.3 Weaknesses and competitive threats 292
16.1.3 BASF SE 293
16.1.3.1 Business overview 293
16.1.3.2 Product/Solutions/Services offered 294
16.1.3.3 Recent developments 295
16.1.3.3.1 Deals 295
16.1.3.3.2 Other developments 296
16.1.3.4 MnM view 296
16.1.3.4.1 Right to win 296
16.1.3.4.2 Strategic choices 296
16.1.3.4.3 Weaknesses and competitive threats 297
16.1.4 ASSOCIATED BRITISH FOODS PLC 298
16.1.4.1 Business overview 298
16.1.4.2 Product/Solutions/Services offered 299
16.1.4.3 Recent developments 301
16.1.4.3.1 Product launches 301
16.1.4.4 MnM view 302
16.1.4.4.1 Right to win 302
16.1.4.4.2 Strategic choices 302
16.1.4.4.3 Weaknesses and competitive threats 302
16.1.5 SENSIENT TECHNOLOGIES CORPORATION 303
16.1.5.1 Business overview 303
16.1.5.2 Product/Solutions/Services offered 304
16.1.5.3 Recent developments 306
16.1.5.3.1 Deals 306
16.1.5.4 MnM view 307
16.1.5.4.1 Right to win 307
16.1.5.4.2 Strategic choices 307
16.1.5.4.3 Weaknesses and competitive threats 307
16.1.6 CARGILL, INCORPORATED 308
16.1.6.1 Business overview 308
16.1.6.2 Product/Solutions/Services offered 309
16.1.6.3 Recent developments 311
16.1.6.3.1 Expansions 311
16.1.6.4 MnM view 312
16.1.6.4.1 Right to win 312
16.1.6.4.2 Strategic choices 312
16.1.6.4.3 Weaknesses and competitive threats 312
16.1.7 AZELIS 313
16.1.7.1 Business overview 313
16.1.7.2 Product/Solutions/Services offered 314
16.1.7.3 Recent developments 315
16.1.7.3.1 Deals 315
16.1.7.3.2 Expansions 317
16.1.7.4 MnM view 318
16.1.7.4.1 Right to win 318
16.1.7.4.2 Strategic choices 318
16.1.7.4.3 Weaknesses and competitive threats 318
16.1.8 ASHLAND 319
16.1.8.1 Business overview 319
16.1.8.2 Product/Solutions/Services offered 320
16.1.8.3 Recent developments 322
16.1.8.3.1 Product launches 322
16.1.8.3.2 Other developments 322
16.1.8.4 MnM view 323
16.1.8.4.1 Right to win 323
16.1.8.4.2 Strategic choices 323
16.1.8.4.3 Weaknesses and competitive threats 323
16.1.9 MEGGLE HOLDING SE 324
16.1.9.1 Business overview 324
16.1.9.2 Product/Solutions/Services offered 324
16.1.9.3 Recent developments 326
16.1.9.3.1 Product launches 326
16.1.9.4 MnM view 327
16.1.9.4.1 Right to win 327
16.1.9.4.2 Strategic choices 327
16.1.9.4.3 Weaknesses and competitive threats 327
16.1.10 ROQUETTE FRÈRES 328
16.1.10.1 Business overview 328
16.1.10.2 Product/Solutions/Services offered 329
16.1.10.3 Recent developments 331
16.1.10.3.1 Product launches 331
16.1.10.3.2 Deals 333
16.1.10.3.3 Expansions 334
16.1.10.4 MnM view 335
16.1.10.4.1 Right to win 335
16.1.10.4.2 Strategic choices 336
16.1.10.4.3 Weaknesses and competitive threats 336
16.1.11 COLORCON, INC. 337
16.1.11.1 Business overview 337
16.1.11.2 Product/Solutions/Services offered 338
16.1.11.3 Recent developments 340
16.1.11.3.1 Product launches 340
16.1.11.3.2 Deals 340
16.1.11.3.3 Expansions 341
16.1.11.3.4 Other developments 342
16.1.11.4 MnM view 342
16.1.11.4.1 Right to win 342
16.1.11.4.2 Strategic choices 342
16.1.11.4.3 Weaknesses and competitive threats 342
16.1.12 ALSIANO A/S 343
16.1.12.1 Business overview 343
16.1.12.2 Product/Solutions/Services offered 343
16.1.12.3 Recent developments 346
16.1.12.4 MnM view 346
16.1.12.4.1 Right to win 346
16.1.12.4.2 Strategic choices 347
16.1.12.4.3 Weaknesses and competitive threats 347
16.1.13 JIGS CHEMICAL 348
16.1.13.1 Business overview 348
16.1.13.2 Product/Solutions/Services offered 348
16.1.13.3 MnM view 350
16.1.13.3.1 Right to win 350
16.1.13.3.2 Strategic choices 350
16.1.13.3.3 Weaknesses and competitive threats 350
16.1.14 IMCD 351
16.1.14.1 Business overview 351
16.1.14.2 Product/Solutions/Services offered 352
16.1.14.3 Recent developments 353
16.1.14.3.1 Deals 353
16.1.14.3.2 Expansions 355
16.1.14.4 MnM view 356
16.1.14.4.1 Right to win 356
16.1.14.4.2 Strategic choices 356
16.1.14.4.3 Weaknesses and competitive threats 356
16.1.15 HILMAR CHEESE COMPANY, INC. 357
16.1.15.1 Business overview 357
16.1.15.2 Product/Solutions/Services offered 357
16.1.15.3 Recent developments 358
16.1.15.3.1 Expansions 358
16.1.15.4 MnM view 359
16.1.15.4.1 Right to win 359
16.1.15.4.2 Strategic choices 359
16.1.15.4.3 Weaknesses and competitive threats 359
16.1.16 OMYA 360
16.1.16.1 Business overview 360
16.1.16.2 Product/Solutions/Services offered 360
16.1.16.3 Recent developments 361
16.1.16.3.1 Deals 361
16.1.16.4 MnM view 361

16.1.17 BIOGRUND 362
16.1.17.1 Business overview 362
16.1.17.2 Product/Solutions/Services offered 362
16.1.17.3 Recent developments 363
16.1.17.3.1 Deals 363
16.1.17.3.2 Expansions 364
16.1.17.4 MnM view 364
16.1.18 JRS PHARMA 365
16.1.18.1 Business overview 365
16.1.18.2 Product/Solutions/Services offered 365
16.1.18.3 Recent developments 367
16.1.18.3.1 Product launches 367
16.1.18.3.2 Expansions 367
16.1.18.4 MnM view 368
16.1.19 INNOPHOS 369
16.1.19.1 Business overview 369
16.1.19.2 Product/Solutions/Services offered 369
16.1.19.3 Recent developments 370
16.1.19.3.1 Expansions 370
16.1.19.4 MnM view 370
16.1.20 NOVO EXCIPIENTS PVT. LTD. 371
16.1.20.1 Business overview 371
16.1.20.2 Products offered 371
16.1.20.3 MnM view 372
16.1.21 PANCHAMRUT CHEMICALS 373
16.1.22 GATTEFOSSÉ 374
16.1.23 FUJI CHEMICAL INDUSTRIES CO., LTD. 375
16.1.24 SUDEEP PHARMA LIMITED 376
16.1.25 SŌRSE TECHNOLOGIES 377
17 RESEARCH METHODOLOGY 378
17.1 RESEARCH DATA 378
17.1.1 SECONDARY DATA 379
17.1.1.1 Key data from secondary sources 380
17.1.2 PRIMARY DATA 380
17.1.2.1 Key data from primary sources 381
17.1.2.2 Key primary participants 381
17.1.2.2.1 Nutraceutical excipients companies 381
17.1.2.3 Breakdown of primary interviews 382
17.1.2.4 Key industry insights 382

17.2 MARKET SIZE ESTIMATION 383
17.2.1 BOTTOM-UP APPROACH 384
17.2.2 TOP-DOWN APPROACH 385
17.2.3 TOP-DOWN APPROACH 387
17.3 DATA TRIANGULATION 388
17.4 FACTOR ANALYSIS 389
17.5 RESEARCH ASSUMPTIONS 390
17.6 RESEARCH LIMITATIONS 391
18 APPENDIX 392
18.1 DISCUSSION GUIDE 392
18.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 398
18.3 RELATED REPORTS 400
18.4 AUTHOR DETAILS 401

LIST OF TABLES

TABLE 1 INCLUSIONS AND EXCLUSIONS 37
TABLE 2 USD EXCHANGE RATES, 2020–2024 39
TABLE 3 GLOBAL PREVALENCE OF ANEMIA, 2024–2025 57
TABLE 4 UNMET NEEDS AND WHITE SPACES IN NUTRACEUTICAL EXCIPIENTS MARKET 63
TABLE 5 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 64
TABLE 6 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 65
TABLE 7 NUTRACEUTICAL EXCIPIENTS MARKET: PORTER’S FIVE FORCES ANALYSIS 67
TABLE 8 NUTRACEUTICAL EXCIPIENTS MARKET: ECOSYSTEM 76
TABLE 9 INDICATIVE AVERAGE SELLING PRICE (ASP) OF NUTRACEUTICAL EXCIPIENTS
BY KEY PLAYERS, 2024 (USD/MT) 77
TABLE 10 INDICATIVE PRICING ANALYSIS FOR NUTRACEUTICAL EXCIPIENTS, BY SOURCE, 2023–2024 (USD/KG) 78
TABLE 11 AVERAGE SELLING PRICE (ASP), BY REGION, 2020–2024 (USD/KG) 79
TABLE 12 NUTRACEUTICAL EXCIPIENTS MARKET: DETAILED LIST OF CONFERENCES & EVENTS, 2025–2026 86
TABLE 13 US-ADJUSTED RECIPROCAL TARIFF RATES 90
TABLE 14 EXPECTED IMPACT LEVEL ON TARGET PRODUCTS WITH RELEVANT HS CODES DUE TO TRUMP TARIFF IMPACT 91
TABLE 15 EXPECTED TARIFF IMPACT ON END-USE INDUSTRIES: NUTRACEUTICAL EXCIPIENT 92
TABLE 16 TECHNOLOGY/PRODUCT MAP FOR NUTRACEUTICAL EXCIPIENTS MARKET 96
TABLE 17 LIST OF MAJOR PATENTS ABOUT NUTRACEUTICAL EXCIPIENTS MARKET,
2021–2024 98
TABLE 18 NUTRACEUTICAL EXCIPIENTS MARKET: FUTURE APPLICATIONS 103
TABLE 19 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 110
TABLE 20 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 111
TABLE 21 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 112
TABLE 22 SOUTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 113
TABLE 23 ROW: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 113
TABLE 24 DEFINITIONS & REGULATIONS FOR NUTRACEUTICAL EXCIPIENTS WORLDWIDE 114
TABLE 25 DEFINITIONS & REGULATIONS FOR NUTRACEUTICALS WORLDWIDE 117
TABLE 26 SCHEDULE – XI OF FOOD SAFETY AND STANDARDS REGULATIONS,
2015, FOR LIST OF APPROVED PREBIOTIC EXCIPIENTS 122
TABLE 27 LIST OF ACCEPTED DIETARY FIBERS BY CANADIAN REGULATORY AUTHORITIES & THEIR SOURCES 123
TABLE 28 KEY INDUSTRY STANDARDS FOR NUTRACEUTICAL EXCIPIENTS MARKET 124
TABLE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR NUTRACEUTICAL EXCIPIENT SOURCE 132
TABLE 30 KEY BUYING CRITERIA FOR NUTRACEUTICAL EXCIPIENT END PRODUCT 133
TABLE 31 NUTRACEUTICAL EXCIPIENTS MARKET, BY MATERIAL, 2020–2024 (USD MILLION) 138
TABLE 32 NUTRACEUTICAL EXCIPIENTS MARKET, BY MATERIAL, 2025–2030 (USD MILLION) 138
TABLE 33 NUTRACEUTICAL EXCIPIENTS MARKET IN PROBIOTICS, BY REGION,
2020–2024 (USD MILLION) 139
TABLE 34 NUTRACEUTICAL EXCIPIENTS MARKET IN PROBIOTICS, BY REGION,
2025–2030 (USD MILLION) 139
TABLE 35 NUTRACEUTICAL EXCIPIENTS MARKET IN PREBIOTICS, BY REGION,
2020–2024 (USD MILLION) 140
TABLE 36 NUTRACEUTICAL EXCIPIENTS MARKET IN PREBIOTICS, BY REGION,
2025–2030 (USD MILLION) 141
TABLE 37 NUTRACEUTICAL EXCIPIENTS MARKET IN PROTEINS & AMINO ACIDS, BY REGION, 2020–2024 (USD MILLION) 142
TABLE 38 NUTRACEUTICAL EXCIPIENTS MARKET IN PROTEINS & AMINO ACIDS, BY REGION, 2025–2030 (USD MILLION) 142
TABLE 39 LIST OF NUTRIENTS AND THEIR RELEVANCE 143
TABLE 40 NUTRACEUTICAL EXCIPIENTS MARKET IN VITAMINS, BY REGION,
2020–2024 (USD MILLION) 143
TABLE 41 NUTRACEUTICAL EXCIPIENTS MARKET IN VITAMINS, BY REGION,
2025–2030 (USD MILLION) 144
TABLE 42 NUTRACEUTICAL EXCIPIENTS MARKET IN MINERALS, BY REGION,
2020–2024 (USD MILLION) 145
TABLE 43 NUTRACEUTICAL EXCIPIENTS MARKET IN MINERALS, BY REGION,
2025–2030 (USD MILLION) 145
TABLE 44 NUTRACEUTICAL EXCIPIENTS MARKET IN OMEGA-3 FATTY ACIDS, BY REGION, 2020–2024 (USD MILLION) 146
TABLE 45 NUTRACEUTICAL EXCIPIENTS MARKET IN OMEGA-3 FATTY ACIDS, BY REGION, 2025–2030 (USD MILLION) 146
TABLE 46 NUTRACEUTICAL EXCIPIENTS MARKET IN OTHER END PRODUCTS, BY REGION, 2020–2024 (USD MILLION) 147
TABLE 47 NUTRACEUTICAL EXCIPIENTS MARKET IN OTHER END PRODUCTS, BY REGION, 2025–2030 (USD MILLION) 147
TABLE 48 NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE, 2020–2024 (USD MILLION) 149
TABLE 49 NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 150
TABLE 50 ORGANIC NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION,
2020–2024 (USD MILLION) 150
TABLE 51 ORGANIC NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION,
2025–2030 (USD MILLION) 151
TABLE 52 ORGANIC NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE,
2020–2024 (USD MILLION) 151
TABLE 53 ORGANIC NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE,
2025–2030 (USD MILLION) 151
TABLE 54 OLEOCHEMICAL NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE,
2020–2024 (USD MILLION) 152
TABLE 55 OLEOCHEMICAL NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE,
2025–2030 (USD MILLION) 152
TABLE 56 CARBOHYDRATE-BASED NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE, 2020–2024 (USD MILLION) 154
TABLE 57 CARBOHYDRATE-BASED NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE, 2025–2030 (USD MILLION) 154
TABLE 58 SUGAR-BASED NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE,
2020–2024 (USD MILLION) 155
TABLE 59 SUGAR-BASED NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE,
2025–2030 (USD MILLION) 155
TABLE 60 CELLULOSE-BASED NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE,
2020–2024 (USD MILLION) 157
TABLE 61 CELLULOSE-BASED NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE,
2025–2030 (USD MILLION) 157
TABLE 62 STARCH-BASED NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE,
2020–2024 (USD MILLION) 160
TABLE 63 STARCH-BASED NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE,
2025–2030 (USD MILLION) 160
TABLE 64 PETROCHEMICAL NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE,
2020–2024 (USD MILLION) 162
TABLE 65 PETROCHEMICAL NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE,
2025–2030 (USD MILLION) 162
TABLE 66 INORGANIC NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION,
2020–2024 (USD MILLION) 165
TABLE 67 INORGANIC NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION,
2025–2030 (USD MILLION) 165
TABLE 68 INORGANIC NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE,
2020–2024 (USD MILLION) 166
TABLE 69 INORGANIC NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE,
2025–2030 (USD MILLION) 166
TABLE 70 OTHER CHEMICAL-BASED NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2020–2024 (USD MILLION) 169
TABLE 71 OTHER CHEMICAL-BASED NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2025–2030 (USD MILLION) 169
TABLE 72 NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION,
2020–2024 (USD MILLION) 171
TABLE 73 NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION,
2025–2030 (USD MILLION) 171
TABLE 74 NUTRACEUTICAL EXCIPIENTS MARKET FOR TASTE MASKING, BY REGION,
2020–2024 (USD MILLION) 173
TABLE 75 NUTRACEUTICAL EXCIPIENTS MARKET FOR TASTE MASKING, BY REGION,
2025–2030 (USD MILLION) 173
TABLE 76 NUTRACEUTICAL EXCIPIENTS MARKET FOR STABILIZERS, BY REGION,
2020–2024 (USD MILLION) 174
TABLE 77 NUTRACEUTICAL EXCIPIENTS MARKET FOR STABILIZERS, BY REGION,
2025–2030 (USD MILLION) 174
TABLE 78 NUTRACEUTICAL EXCIPIENTS MARKET FOR MODIFIED RELEASE, BY REGION, 2020–2024 (USD MILLION) 175
TABLE 79 NUTRACEUTICAL EXCIPIENTS MARKET FOR MODIFIED RELEASE, BY REGION, 2025–2030 (USD MILLION) 175
TABLE 80 NUTRACEUTICAL EXCIPIENTS MARKET FOR SOLUBILITY & BIOAVAILABILITY ENHANCEMENT, BY REGION, 2020–2024 (USD MILLION) 176
TABLE 81 NUTRACEUTICAL EXCIPIENTS MARKET FOR SOLUBILITY & BIOAVAILABILITY ENHANCEMENT, BY REGION, 2025–2030 (USD MILLION) 176
TABLE 82 NUTRACEUTICAL EXCIPIENTS MARKET FOR OTHER FUNCTIONALITY APPLICATIONS, BY REGION, 2020–2024 (USD MILLION) 177
TABLE 83 NUTRACEUTICAL EXCIPIENTS MARKET FOR OTHER FUNCTIONALITY APPLICATIONS, BY REGION, 2025–2030 (USD MILLION) 177
TABLE 84 NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION,
2020–2024 (USD MILLION) 179
TABLE 85 NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION,
2025–2030 (USD MILLION) 179
TABLE 86 DRY NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION,
2020–2024 (USD MILLION) 181
TABLE 87 DRY NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION,
2025–2030 (USD MILLION) 181
TABLE 88 DRY NUTRACEUTICAL EXCIPIENTS MARKET, BY DRY FORMULATION,
2020–2024 (USD MILLION) 181
TABLE 89 DRY NUTRACEUTICAL EXCIPIENTS MARKET, BY DRY FORMULATION,
2025–2030 (USD MILLION) 182
TABLE 90 LIQUID NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION,
2020–2024 (USD MILLION) 183
TABLE 91 LIQUID NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION,
2025–2030 (USD MILLION) 183
TABLE 92 OTHER NUTRACEUTICAL EXCIPIENT FORMULATIONS MARKET, BY REGION,
2020–2024 (USD MILLION) 184
TABLE 93 OTHER NUTRACEUTICAL EXCIPIENT FORMULATIONS MARKET, BY REGION,
2025–2030 (USD MILLION) 184
TABLE 94 NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,
2020–2024 (USD MILLION) 186
TABLE 95 NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,
2025–2030 (USD MILLION) 187
TABLE 96 NUTRACEUTICAL EXCIPIENTS MARKET IN BINDERS, BY REGION,
2020–2024 (USD MILLION) 188
TABLE 97 NUTRACEUTICAL EXCIPIENTS MARKET IN BINDERS, BY REGION,
2025–2030 (USD MILLION) 188
TABLE 98 NUTRACEUTICAL EXCIPIENTS MARKET IN FILLERS & DILUENTS, BY REGION,
2020–2024 (USD MILLION) 189
TABLE 99 NUTRACEUTICAL EXCIPIENTS MARKET IN FILLERS & DILUENTS, BY REGION,
2025–2030 (USD MILLION) 190
TABLE 100 NUTRACEUTICAL EXCIPIENTS MARKET IN DISINTEGRANTS, BY REGION,
2020–2024 (USD MILLION) 191
TABLE 101 NUTRACEUTICAL EXCIPIENTS MARKET IN DISINTEGRANTS, BY REGION,
2025–2030 (USD MILLION) 191
TABLE 102 NUTRACEUTICAL EXCIPIENTS MARKET IN COATING AGENTS, BY REGION,
2020–2024 (USD MILLION) 192
TABLE 103 NUTRACEUTICAL EXCIPIENTS MARKET IN COATING AGENTS, BY REGION,
2025–2030 (USD MILLION) 192
TABLE 104 NUTRACEUTICAL EXCIPIENTS MARKET IN FLAVORING AGENTS & SWEETENERS,
BY REGION, 2020–2024 (USD MILLION) 193
TABLE 105 NUTRACEUTICAL EXCIPIENTS MARKET IN FLAVORING AGENTS & SWEETENERS,
BY REGION, 2025–2030 (USD MILLION) 193
TABLE 106 NUTRACEUTICAL EXCIPIENTS MARKET IN PRESERVATIVES, BY REGION,
2020–2024 (USD MILLION) 194
TABLE 107 NUTRACEUTICAL EXCIPIENTS MARKET IN PRESERVATIVES, BY REGION,
2025–2030 (USD MILLION) 194
TABLE 108 NUTRACEUTICAL EXCIPIENTS MARKET IN LUBRICANTS & GLIDANTS, BY REGION, 2020–2024 (USD MILLION) 195
TABLE 109 NUTRACEUTICAL EXCIPIENTS MARKET IN LUBRICANTS & GLIDANTS, BY REGION, 2025–2030 (USD MILLION) 195
TABLE 110 NUTRACEUTICAL EXCIPIENTS MARKET IN SUSPENDING & VISCOSITY AGENTS,
BY REGION, 2020–2024 (USD MILLION) 196
TABLE 111 NUTRACEUTICAL EXCIPIENTS MARKET IN SUSPENDING & VISCOSITY AGENTS,
BY REGION, 2025–2030 (USD MILLION) 196
TABLE 112 NUTRACEUTICAL EXCIPIENTS MARKET IN COLORANTS, BY REGION,
2020–2024 (USD MILLION) 197
TABLE 113 NUTRACEUTICAL EXCIPIENTS MARKET IN COLORANTS, BY REGION,
2025–2030 (USD MILLION) 197
TABLE 114 NUTRACEUTICAL EXCIPIENTS MARKET IN EMULSIFYING AGENTS, BY REGION, 2020–2024 (USD MILLION) 198
TABLE 115 NUTRACEUTICAL EXCIPIENTS MARKET IN EMULSIFYING AGENTS, BY REGION, 2025–2030 (USD MILLION) 198
TABLE 116 NUTRACEUTICAL EXCIPIENTS MARKET IN OTHER FUNCTIONALITIES, BY REGION, 2020–2024 (USD MILLION) 199
TABLE 117 NUTRACEUTICAL EXCIPIENTS MARKET IN OTHER FUNCTIONALITIES, BY REGION, 2025–2030 (USD MILLION) 199
TABLE 118 NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2020–2024 (USD MILLION) 202
TABLE 119 NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2025–2030 (USD MILLION) 203
TABLE 120 NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2020–2024 (KT) 203
TABLE 121 NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2025–2030 (KT) 203
TABLE 122 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY COUNTRY,
2020–2024 (USD MILLION) 205
TABLE 123 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY COUNTRY,
2025–2030 (USD MILLION) 205
TABLE 124 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE,
2020–2024 (USD MILLION) 205
TABLE 125 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE,
2025–2030 (USD MILLION) 205
TABLE 126 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION) 206
TABLE 127 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION) 206
TABLE 128 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2020–2024 (USD MILLION) 207
TABLE 129 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2025–2030 (USD MILLION) 207
TABLE 130 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2020–2024 (USD MILLION) 207
TABLE 131 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2025–2030 (USD MILLION) 208
TABLE 132 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2020–2024 (USD MILLION) 208
TABLE 133 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2025–2030 (USD MILLION) 208
TABLE 134 US: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,
2020–2024 (USD MILLION) 209
TABLE 135 US: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,
2025–2030 (USD MILLION) 210
TABLE 136 CANADA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,
2020–2024 (USD MILLION) 211
TABLE 137 CANADA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,
2025–2030 (USD MILLION) 211
TABLE 138 MEXICO: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,
2020–2024 (USD MILLION) 212
TABLE 139 MEXICO: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,
2025–2030 (USD MILLION) 213
TABLE 140 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY COUNTRY,
2020–2024 (USD MILLION) 214
TABLE 141 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY COUNTRY,
2025–2030 (USD MILLION) 214
TABLE 142 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE,
2020–2024 (USD MILLION) 215
TABLE 143 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE,
2025–2030 (USD MILLION) 215
TABLE 144 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,
2020–2024 (USD MILLION) 215
TABLE 145 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,
2025–2030 (USD MILLION) 216
TABLE 146 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION,
2020–2024 (USD MILLION) 216
TABLE 147 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION,
2025–2030 (USD MILLION) 216
TABLE 148 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT,
2020–2024 (USD MILLION) 217
TABLE 149 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT,
2025–2030 (USD MILLION) 217
TABLE 150 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2020–2024 (USD MILLION) 217
TABLE 151 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2025–2030 (USD MILLION) 218
TABLE 152 GERMANY: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,
2020–2024 (USD MILLION) 219
TABLE 153 GERMANY: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,
2025–2030 (USD MILLION) 219
TABLE 154 FRANCE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,
2020–2024 (USD MILLION) 220
TABLE 155 FRANCE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,
2025–2030 (USD MILLION) 221
TABLE 156 UK: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,
2020–2024 (USD MILLION) 222
TABLE 157 UK: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,
2025–2030 (USD MILLION) 222
TABLE 158 ITALY: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,
2020–2024 (USD MILLION) 223
TABLE 159 ITALY: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,
2025–2030 (USD MILLION) 224
TABLE 160 SPAIN: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,
2020–2024 (USD MILLION) 225
TABLE 161 SPAIN: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,
2025–2030 (USD MILLION) 225
TABLE 162 REST OF EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION) 226
TABLE 163 REST OF EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION) 227
TABLE 164 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY COUNTRY,
2020–2024 (USD MILLION) 228
TABLE 165 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY COUNTRY,
2025–2030 (USD MILLION) 229
TABLE 166 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE,
2020–2024 (USD MILLION) 229
TABLE 167 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE,
2025–2030 (USD MILLION) 229
TABLE 168 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,
2020–2024 (USD MILLION) 230
TABLE 169 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,
2025–2030 (USD MILLION) 230
TABLE 170 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION,
2020–2024 (USD MILLION) 231
TABLE 171 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION,
2025–2030 (USD MILLION) 231
TABLE 172 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT,
2020–2024 (USD MILLION) 231
TABLE 173 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT,
2025–2030 (USD MILLION) 232
TABLE 174 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2020–2024 (USD MILLION) 232
TABLE 175 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2025–2030 (USD MILLION) 232
TABLE 176 CHINA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,
2020–2024 (USD MILLION) 234
TABLE 177 CHINA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,
2025–2030 (USD MILLION) 234
TABLE 178 JAPAN: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,
2020–2024 (USD MILLION) 235
TABLE 179 JAPAN: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,
2025–2030 (USD MILLION) 236
TABLE 180 INDIA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,
2020–2024 (USD MILLION) 237
TABLE 181 INDIA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,
2025–2030 (USD MILLION) 238
TABLE 182 SOUTH KOREA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,
2020–2024 (USD MILLION) 239
TABLE 183 SOUTH KOREA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,
2025–2030 (USD MILLION) 239
TABLE 184 REST OF ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION) 240
TABLE 185 REST OF ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION) 241
TABLE 186 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY COUNTRY,
2020–2024 (USD MILLION) 242
TABLE 187 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY COUNTRY,
2025–2030 (USD MILLION) 242
TABLE 188 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE,
2020–2024 (USD MILLION) 242
TABLE 189 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE,
2025–2030 (USD MILLION) 242
TABLE 190 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION) 243
TABLE 191 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION) 243
TABLE 192 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2020–2024 (USD MILLION) 244
TABLE 193 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2025–2030 (USD MILLION) 244
TABLE 194 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2020–2024 (USD MILLION) 244
TABLE 195 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2025–2030 (USD MILLION) 245
TABLE 196 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2020–2024 (USD MILLION) 245
TABLE 197 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2025–2030 (USD MILLION) 245
TABLE 198 BRAZIL: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,
2020–2024 (USD MILLION) 246
TABLE 199 BRAZIL: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,
2025–2030 (USD MILLION) 247
TABLE 200 ARGENTINA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,
2020–2024 (USD MILLION) 248
TABLE 201 ARGENTINA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,
2025–2030 (USD MILLION) 248
TABLE 202 REST OF SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET,
BY FUNCTIONALITY, 2020–2024 (USD MILLION) 249
TABLE 203 REST OF SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET,
BY FUNCTIONALITY, 2025–2030 (USD MILLION) 250
TABLE 204 ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION,
2020–2024 (USD MILLION) 251
TABLE 205 ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION,
2025–2030 (USD MILLION) 251
TABLE 206 ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE,
2020–2024 (USD MILLION) 251
TABLE 207 ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE,
2025–2030 (USD MILLION) 251
TABLE 208 ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,
2020–2024 (USD MILLION) 252
TABLE 209 ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,
2025–2030 (USD MILLION) 252
TABLE 210 ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION,
2020–2024 (USD MILLION) 253
TABLE 211 ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION,
2025–2030 (USD MILLION) 253
TABLE 212 ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT,
2020–2024 (USD MILLION) 253
TABLE 213 ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT,
2025–2030 (USD MILLION) 254
TABLE 214 ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2020–2024 (USD MILLION) 254
TABLE 215 ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2025–2030 (USD MILLION) 254
TABLE 216 MIDDLE EAST: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,
2020–2024 (USD MILLION) 255
TABLE 217 MIDDLE EAST: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,
2025–2030 (USD MILLION) 256
TABLE 218 AFRICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,
2020–2024 (USD MILLION) 257
TABLE 219 AFRICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,
2025–2030 (USD MILLION) 257
TABLE 220 COMPETITIVE STRATEGIES ADOPTED BY KEY PLAYERS IN NUTRACEUTICAL EXCIPIENTS MARKET, 2020–2024 259
TABLE 221 NUTRACEUTICAL EXCIPIENTS MARKET: DEGREE OF COMPETITION 263
TABLE 222 NUTRACEUTICAL EXCIPIENTS MARKET: REGION FOOTPRINT 269
TABLE 223 NUTRACEUTICAL EXCIPIENTS MARKET: SOURCE FOOTPRINT 270
TABLE 224 NUTRACEUTICAL EXCIPIENTS MARKET: FUNCTIONALITY FOOTPRINT 271
TABLE 225 NUTRACEUTICAL EXCIPIENTS MARKET: FUNCTIONALITY APPLICATION FOOTPRINT 272
TABLE 226 NUTRACEUTICAL EXCIPIENTS MARKET: KEY STARTUPS/SMES 275
TABLE 227 NUTRACEUTICAL EXCIPIENTS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES, 2024 276
TABLE 228 NUTRACEUTICAL EXCIPIENTS MARKET: PRODUCT
LAUNCHES, 2020–NOVEMBER 2025 278
TABLE 229 NUTRACEUTICAL EXCIPIENTS MARKET: DEALS, 2020–NOVEMBER 2025 279
TABLE 230 NUTRACEUTICAL EXCIPIENTS MARKET: EXPANSIONS, 2020–NOVEMBER 2025 282
TABLE 231 NUTRACEUTICAL EXCIPIENTS MARKET: OTHER DEVELOPMENTS,
2020–NOVEMBER 2025 283
TABLE 232 KERRY GROUP PLC: BUSINESS OVERVIEW 284
TABLE 233 KERRY GROUP PLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED 285
TABLE 234 KERRY GROUP PLC: DEALS 287
TABLE 235 KERRY GROUP PLC: EXPANSION 288
TABLE 236 INGREDION: BUSINESS OVERVIEW 289
TABLE 237 INGREDION: PRODUCTS/SOLUTIONS/SERVICES OFFERED 290
TABLE 238 INGREDION: DEALS 291
TABLE 239 BASF SE: BUSINESS OVERVIEW 293
TABLE 240 BASF SE: PRODUCTS/SOLUTIONS/SERVICES OFFERED 294
TABLE 241 BASF SE: DEALS 295
TABLE 242 BASF SE: OTHER DEVELOPMENTS 296
TABLE 243 ASSOCIATED BRITISH FOODS PLC: BUSINESS OVERVIEW 298
TABLE 244 ASSOCIATED BRITISH FOODS PLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED 299
TABLE 245 ASSOCIATED BRITISH FOODS PLC: PRODUCT LAUNCHES 301
TABLE 246 SENSIENT TECHNOLOGIES CORPORATION: BUSINESS OVERVIEW 303
TABLE 247 SENSIENT TECHNOLOGIES CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED 304
TABLE 248 SENSIENT TECHNOLOGIES CORPORATION: DEALS 306
TABLE 249 CARGILL, INCORPORATED: BUSINESS OVERVIEW 308
TABLE 250 CARGILL, INCORPORATED: PRODUCTS/SOLUTIONS/SERVICES OFFERED 309
TABLE 251 CARGILL, INCORPORATED: EXPANSIONS 311
TABLE 252 AZELIS: BUSINESS OVERVIEW 313
TABLE 253 AZELIS: PRODUCTS/SOLUTIONS/SERVICES OFFERED 314
TABLE 254 AZELIS: DEALS 315
TABLE 255 AZELIS: EXPANSIONS 317
TABLE 256 ASHLAND: BUSINESS OVERVIEW 319
TABLE 257 ASHLAND: PRODUCTS/SOLUTIONS/SERVICES OFFERED 320
TABLE 258 ASHLAND: PRODUCT LAUNCHES 322
TABLE 259 ASHLAND: OTHER DEVELOPMENTS 322
TABLE 260 MEGGLE HOLDING SE: BUSINESS OVERVIEW 324
TABLE 261 MEGGLE HOLDING SE: PRODUCTS/SOLUTIONS/SERVICES OFFERED 324
TABLE 262 MEGGLE HOLDING SE: PRODUCT LAUNCHES 326
TABLE 263 ROQUETTE FRÈRES: BUSINESS OVERVIEW 328
TABLE 264 ROQUETTE FRÈRES: PRODUCTS/SOLUTIONS/SERVICES OFFERED 329
TABLE 265 ROQUETTE FRÈRES: PRODUCT LAUNCHES 331
TABLE 266 ROQUETTE FRÈRES: DEALS 333
TABLE 267 ROQUETTE FRÈRES: EXPANSIONS 334
TABLE 268 COLORCON, INC.: BUSINESS OVERVIEW 337
TABLE 269 COLORCON, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 338
TABLE 270 COLORCON, INC.: PRODUCT LAUNCHES 340
TABLE 271 COLORCON, INC.: DEALS 340
TABLE 272 COLORCON, INC.: EXPANSIONS 341
TABLE 273 COLORCON, INC.: OTHER DEVELOPMENTS 342
TABLE 274 ALSIANO A/S: BUSINESS OVERVIEW 343
TABLE 275 ALSIANO A/S: PRODUCTS/SOLUTIONS/SERVICES OFFERED 343
TABLE 276 ALSIANO A/S: DEALS 346
TABLE 277 JIGS CHEMICAL: BUSINESS OVERVIEW 348
TABLE 278 JIGS CHEMICAL: PRODUCTS/SOLUTIONS/SERVICES OFFERED 348
TABLE 279 IMCD: BUSINESS OVERVIEW 351
TABLE 280 IMCD: PRODUCTS/SOLUTIONS/SERVICES OFFERED 352
TABLE 281 IMCD: DEALS 353
TABLE 282 IMCD: EXPANSIONS 355
TABLE 283 HILMAR CHEESE COMPANY, INC.: BUSINESS OVERVIEW 357
TABLE 284 HILMAR CHEESE COMPANY, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 357
TABLE 285 HILMAR CHEESE COMPANY, INC.: EXPANSIONS 358
TABLE 286 OMYA: BUSINESS OVERVIEW 360
TABLE 287 OMYA: PRODUCTS/SOLUTIONS/SERVICES OFFERED 360
TABLE 288 OMYA: DEALS 361
TABLE 289 BIOGRUND: BUSINESS OVERVIEW 362
TABLE 290 BIOGRUND: PRODUCTS/SOLUTIONS/SERVICES OFFERED 362
TABLE 291 BIOGRUND: DEALS 363
TABLE 292 BIOGRUND: EXPANSIONS 364
TABLE 293 JRS PHARMA: BUSINESS OVERVIEW 365
TABLE 294 JRS PHARMA: PRODUCTS/SOLUTIONS/SERVICES OFFERED 365
TABLE 295 JRS PHARMA: PRODUCT LAUNCHES 367
TABLE 296 JRS PHARMA: EXPANSIONS 367
TABLE 297 INNOPHOS: BUSINESS OVERVIEW 369
TABLE 298 INNOPHOS: PRODUCTS/SOLUTIONS/SERVICES OFFERED 369
TABLE 299 INNOPHOS: EXPANSIONS 370
TABLE 300 NOVO EXCIPIENTS PVT. LTD.: BUSINESS OVERVIEW 371
TABLE 301 NOVO EXCIPIENTS PVT. LTD.: PRODUCTS OFFERED 371
TABLE 302 PANCHAMRUT CHEMICALS: COMPANY OVERVIEW 373
TABLE 303 GATTEFOSSÉ: COMPANY OVERVIEW 374
TABLE 304 FUJI CHEMICAL INDUSTRIES CO., LTD.: COMPANY OVERVIEW 375
TABLE 305 SUDEEP PHARMA LIMITED: COMPANY OVERVIEW 376
TABLE 306 SŌRSE TECHNOLOGIES: COMPANY OVERVIEW 377

LIST OF FIGURES

FIGURE 1 NUTRACEUTICAL EXCIPIENTS MARKET SEGMENTATION 36
FIGURE 2 STUDY YEARS CONSIDERED 38
FIGURE 3 KEY INSIGHTS AND MARKET HIGHLIGHTS 42
FIGURE 4 GLOBAL NUTRACEUTICAL EXCIPIENTS MARKET, 2021–2030 (USD MILLION) 42
FIGURE 5 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN NUTRACEUTICAL
EXCIPIENTS MARKET, 2020–2025 43
FIGURE 6 DISRUPTIVE TRENDS IMPACTING GROWTH OF NUTRACEUTICAL EXCIPIENTS MARKET DURING FORECAST PERIOD 44
FIGURE 7 HIGH-GROWTH SEGMENTS AND EMERGING FRONTIERS IN NUTRACEUTICAL EXCIPIENTS MARKET, 2025–2030 45
FIGURE 8 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 46
FIGURE 9 INCREASING DEMAND FOR HIGH-QUALITY EXCIPIENTS ENABLING EFFECTIVE TABLET AND CAPSULE NUTRACEUTICAL FORMULATIONS 48
FIGURE 10 ORGANIC CHEMICALS SEGMENT AND NORTH AMERICA ACCOUNTED FOR LARGEST SEGMENTAL SHARES IN 2024 49
FIGURE 11 NORTH AMERICA DOMINATED NUTRACEUTICAL EXCIPIENTS MARKET IN 2024 50
FIGURE 12 DRY SEGMENT DOMINATED NUTRACEUTICAL EXCIPIENTS MARKET IN 2024 50
FIGURE 13 ORGANIC CHEMICALS SEGMENT DOMINATED NUTRACEUTICAL EXCIPIENTS MARKET IN 2024 51
FIGURE 14 MODIFIED RELEASE SEGMENTS DOMINATED NUTRACEUTICAL EXCIPIENTS MARKET IN 2024 51
FIGURE 15 PROBIOTICS SEGMENT DOMINATED NUTRACEUTICAL EXCIPIENTS
MARKET IN 2024 52
FIGURE 16 INDIA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 52
FIGURE 17 NUTRACEUTICAL EXCIPIENTS MARKET DYNAMICS 53
FIGURE 18 NUMBER OF AMERICANS WITH CHRONIC CONDITIONS, 1995–2030 (MILLION) 55
FIGURE 19 PORTER’S FIVE FORCES ANALYSIS: NUTRACEUTICAL EXCIPIENTS MARKET 68
FIGURE 20 US: POPULATION AGED 65 AND OLDER, 2000–2060 (MILLION) 72
FIGURE 21 KEY MARKET DRIVERS SHAPING INNOVATION, ADOPTION, AND GROWTH DYNAMICS ACROSS GLOBAL NUTRACEUTICAL EXCIPIENT INDUSTRY IN RESPONSE TO EVOLVING FORMULATION DEMANDS 73
FIGURE 22 NUTRACEUTICAL EXCIPIENTS MARKET: VALUE CHAIN ANALYSIS 73
FIGURE 23 NUTRACEUTICAL EXCIPIENTS MARKET: ECOSYSTEM 76
FIGURE 24 AVERAGE SELLING PRICE TREND, BY REGION, 2020–2024 (USD/KG) 79
FIGURE 25 EXPORT VALUE OF NUTRACEUTICAL EXCIPIENTS UNDER HS CODE 210690 FOR KEY COUNTRIES, 2020–2024 (USD THOUSAND) 80
FIGURE 26 IMPORT VALUE OF NUTRACEUTICAL EXCIPIENTS UNDER HS CODE 210690 FOR KEY COUNTRIES, 2020–2024 (USD THOUSAND) 81
FIGURE 27 EXPORT VALUE OF NUTRACEUTICAL EXCIPIENTS UNDER HS CODE 300490 FOR KEY COUNTRIES, 2020–2024 (USD THOUSAND) 82
FIGURE 28 IMPORT VALUE OF NUTRACEUTICAL EXCIPIENTS UNDER HS CODE 300490 FOR KEY COUNTRIES, 2020–2024 (USD THOUSAND) 82
FIGURE 29 EXPORT VALUE OF NUTRACEUTICAL EXCIPIENTS UNDER HS CODE 293090 FOR KEY COUNTRIES, 2020–2024 (USD THOUSAND) 83
FIGURE 30 IMPORT VALUE OF NUTRACEUTICAL EXCIPIENTS UNDER HS CODE 293090 FOR KEY COUNTRIES, 2020–2024 (USD THOUSAND) 84
FIGURE 31 EXPORT VALUE OF NUTRACEUTICAL EXCIPIENTS UNDER HS CODE 382200 FOR KEY COUNTRIES, 2020–2024 (USD THOUSAND) 85
FIGURE 32 IMPORT VALUE OF NUTRACEUTICAL EXCIPIENT UNDER HS CODE 382200 FOR KEY COUNTRIES, 2020–2024 (USD THOUSAND) 86
FIGURE 33 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESS 87
FIGURE 34 INVESTMENT AND FUNDING SCENARIO, 2020–2025 (USD MILLION) 88
FIGURE 35 NUMBER OF PATENTS GRANTED FOR NUTRACEUTICAL EXCIPIENTS MARKET, 2014–2024 97
FIGURE 36 REGIONAL ANALYSIS OF PATENTS GRANTED FOR NUTRACEUTICAL EXCIPIENTS MARKET, 2014–2024 98
FIGURE 37 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR NUTRACEUTICAL EXCIPIENT TYPE 132
FIGURE 38 KEY BUYING CRITERIA FOR NUTRACEUTICAL EXCIPIENT END PRODUCT 133
FIGURE 39 PROTEIN & AMINO ACIDS TO LEAD DURING FORECAST PERIOD 137
FIGURE 40 NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE, 2025 VS. 2030 (USD MILLION) 149
FIGURE 41 NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION,
2025 VS. 2030 172
FIGURE 42 NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION,
2025 VS. 2030 (USD MILLION) 180
FIGURE 43 NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,
2025 VS. 2030 (USD MILLION) 187
FIGURE 44 ITALY, CHINA, INDIA, AND SOUTH KOREA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 202
FIGURE 45 NORTH AMERICA: MARKET SNAPSHOT 204
FIGURE 46 ASIA PACIFIC: MARKET SNAPSHOT 228
FIGURE 47 NUTRACEUTICAL EXCIPIENTS MARKET: REVENUE ANALYSIS FOR
FIVE KEY PLAYERS, 2022–2024 (USD BILLION) 261
FIGURE 48 SHARE OF LEADING COMPANIES IN NUTRACEUTICAL EXCIPIENTS MARKET, 2024 263
FIGURE 49 BRAND/PRODUCT COMPARISON 264
FIGURE 50 NUTRACEUTICAL EXCIPIENTS MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2024 267
FIGURE 51 NUTRACEUTICAL EXCIPIENTS MARKET: COMPANY FOOTPRINT 268
FIGURE 52 NUTRACEUTICAL EXCIPIENTS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 274
FIGURE 53 COMPANY VALUATION OF KEY NUTRACEUTICAL EXCIPIENTS MANUFACTURERS 277
FIGURE 54 EV/EBITDA OF KEY COMPANIES 277
FIGURE 55 KERRY GROUP PLC: COMPANY SNAPSHOT 285
FIGURE 56 INGREDION: COMPANY SNAPSHOT 290
FIGURE 57 BASF SE: COMPANY SNAPSHOT 294
FIGURE 58 ASSOCIATED BRITISH FOODS PLC: COMPANY SNAPSHOT 299
FIGURE 59 SENSIENT TECHNOLOGIES CORPORATION: COMPANY SNAPSHOT 304
FIGURE 60 CARGILL, INCORPORATED: COMPANY SNAPSHOT 309
FIGURE 61 AZELIS: COMPANY SNAPSHOT 314
FIGURE 62 ASHLAND: COMPANY SNAPSHOT 320
FIGURE 63 ROQUETTE FRÈRES: COMPANY SNAPSHOT 329
FIGURE 64 IMCD: COMPANY SNAPSHOT 352
FIGURE 65 NUTRACEUTICAL EXCIPIENTS MARKET: RESEARCH DESIGN 379
FIGURE 66 KEY DATA FROM PRIMARY SOURCES 381
FIGURE 67 BREAKDOWN OF PRIMARY INTERVIEWS, BY COMPANY TYPE, DESIGNATION, AND REGION 382
FIGURE 68 KEY INSIGHTS FROM INDUSTRY EXPERTS 382
FIGURE 69 BRIEF OF BOTTOM-UP APPROACH 384
FIGURE 70 NUTRACEUTICAL EXCIPIENTS MARKET: BOTTOM-UP APPROACH 385
FIGURE 71 NUTRACEUTICAL EXCIPIENTS MARKET: TOP-DOWN APPROACH 386
FIGURE 72 BRIEF OF TOP-DOWN APPROACH 387
FIGURE 73 DATA TRIANGULATION 388
FIGURE 74 FACTOR ANALYSIS 389
FIGURE 75 RESEARCH ASSUMPTIONS 390
FIGURE 76 RESEARCH LIMITATIONS 391

---

---